Michael Schachter, Anthony S Wierzbicki. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » AdvertisingAtherosclerosis/drug therapyClinical Trials as Topic/methodsDrug IndustryFluorobenzenes/therapeutic useHumansHydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic usePyrimidines/therapeutic useRosuvastatin CalciumSulfonamides/therapeutic use
Substances： See more » FluorobenzenesHydroxymethylglutaryl-CoA Reductase InhibitorsPyrimidinesSulfonamidesRosuvastatin Calcium
Year: 2006 PMID： 16714182 DOI： 10.1016/S0140-6736(06)68728-X
Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321